National and Kapodistrian University of Athens
Ο ρόλος των προσταγλανδινών της λευκοτριένης Β4 και των μη στεροειδών αντιφλεγμονωδών φαρμάκων στην καρκινογένεση του παχέος εντέρου: in vitro και in vivo μελέτη
Abstract
dc:descriptionEicosanoids have been implicated in colon carcinogenesis, but their role remains unclear. The levels of PGE2 are elevated in colon cancer tissues and in blood drained from colon tumours. The effect of eicosanoids on the proliferation on colonic cells is unknown. I studied the effect of several prostaglandins (PGs) and leukοtriene (LT) B4 on the proliferation rate of the human colon cancer adenocarcinoma cell lines SW1116 and HT-29 and of 16, 16,-dimethyl PGE2 (dmPGE2) on the colon of BALB/c mice. PGs E2, F2a, I2 the methyl ester of PGE2, dmPGE2 and LTB4 (10-10, 10-8, 10-6M) administered up to 72 hrs, stimulated proliferation in HT-29 cells. The proliferative effect was time and concetration-depedent. However, in SW1116 cells the response to PGs was “bell-shaped”, being maximal in at 10-8M, with the 10-10 and 10-8 concetrations being less effective. In HT-29 cells, the addition of methyl groups to the PGE2 molecule increased the proliferative effect. None of these eicosanoids affected the distribution of these cells in the cell cycle or their rate of programmed cell death (apoptosis). dmPGE2 stimulated 3.6-fold the proliferation of colonocytes in normal BALB/c mice. This was determined by bivariate flow cytometric analysis of the expression of proliferative cell nuclear antigen (PCNA) in virtually pure populations of mouse colonocytes. dmPGE2 did not alter the cell cycle distribution of these cells. Nonsteroidal antiinflamatory drugs (NSAIDs) decrease the incidence of and mortality from colon cancer. I observed that NSAIDs inhibit the growth rate, alter the cell cycle distribution and induce apoptosis in colon cancer cell lines. I evaluaeted whether NSAIDs inhibition PG synthesis is required for their effects on colon cancer cells by studing two human colon cancer cell lines, HCT-15 and HT-29. HCT-15 which lacks cyclooxygenase transcripts, does not produce PGs even when exogenously stimulated, whereas HT-29 produces PGE2, PGF2a and PGI2. HCT-15 and HT-29 when treated for up to 72 hrs with sulindac sulfide 200μΜ (active metabolite of sulindac) or piroxicam 900μΜ showed changes in proliferation, cell cycle distribution and apoptosis. Treatment with PGE2, PGF2a and PGI2, following a variety of protocols and at concetrations between 10-6 and 10-11 M, failed to reverse the effect of NSAIDs on these three parameters of cell growth. I concluded that several PGs and as well as LTB4 stimulate the proliferation of human colon carcinoma cells in vitro, while dmPGE2 has similar effect on colonocytes in vivo. These findings raise the possibility that eicosanoids may contribute tocolonic carcinogenesis by stimulating the proliferation rate of tumor cells in the colon.I also concluded that NSAIDs inhibit the growth of two colon cancer cell lines indepedent of their ability to inhibit PG synthesis. Thus, alternative mechanisms for their activity on tumor cell growth must be entertained. These observations may be relevant to the mechanism of colon tumor inhibition by NSAIDs.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 1999
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kozoni, Vasiliki
- Κοζώνη, Βασιλική
Subjects
dc:subject × 24- Καρκίνος παχέος εντέρου
- Μη στεροειδή αντιφλεγμονώδη φάρμακα
- ΜΣΑΦ
- Προσταγλανδίνες
- Λευκοτριένη Β4
- Κυτταρικός κύκλος
- Κυτταρικό πολλαπλασιασμός
- Απόπτωση (προγραμματισμένος κυτταρικός θάνατος)
- SW1116
- HT29
- BALB/c ποντίκια
- Colon cancer
- Nonsteroidal anti-inflammatory drugs
- NSAIDs
- Prostaglandins
- Leukotriene B4
- BALB/c mice
- Cell cycle
- Cell proliferation
- Apoptosis
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39673